PF-Atlas › Clinical Trials › NCT07722507

Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis

Antifibrotic therapy · Not specified

Registry ID
NCT07722507
Phase
Not specified
Status
Not yet recruiting
Drug / intervention
Antifibrotic therapy
Sponsor
Bristol-Myers Squibb
Start
2026-08-01
Enrollment
40
Locations
1

About this trial

This study will explore how adults in Japan with pulmonary fibrosis decide whether to continue or discontinue antifibrotic therapy after experiencing antifibrotic therapy-related adverse events.

View NCT07722507 on ClinicalTrials.gov →

Explore related

All Antifibrotic therapy trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT07722507 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.